Literature DB >> 18039831

Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation?

Jaroslaw Zdziarski1, Catharina Svanborg, Björn Wullt, Jörg Hacker, Ulrich Dobrindt.   

Abstract

In some patients, Escherichia coli strains establish significant bacteriuria without causing symptoms of urinary tract infection (UTI). These asymptomatic-bacteriuria (ABU) strains have been shown to express fewer virulence factors than the uropathogenic E. coli (UPEC) strains that cause severe, symptomatic UTI. Paradoxically, ABU strains carry many typical UPEC virulence genes, and the molecular basis of their low virulence therefore remains unclear. This study examined whether ABU strains might evolve from UPEC by genome loss and virulence gene attenuation. The presence of conserved E. coli K-12 genes was examined using an E. coli K-12 strain MG1655-specific DNA array and the distribution of UPEC virulence-related genes was examined with the E. coli pathoarray. Two groups of strains could be distinguished. Several ABU strains were shown by multilocus sequence typing and by comparative genomic analyses to be related to UPEC but to have smaller genome sizes. There were significant alterations in essential virulence genes, including reductive evolution by point mutations, DNA rearrangements, and deletions. Other strains were unrelated to UPEC and lacked most of the virulence-associated genes. The results suggest that some ABU strains arise from virulent strains by attenuation of virulence genes while others are nonvirulent and resemble commensal strains. We propose that virulence attenuation might constitute a general mechanism for mucosal pathogens to evolve toward commensalism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18039831      PMCID: PMC2223460          DOI: 10.1128/IAI.01215-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Artemis: sequence visualization and annotation.

Authors:  K Rutherford; J Parkhill; J Crook; T Horsnell; P Rice; M A Rajandream; B Barrell
Journal:  Bioinformatics       Date:  2000-10       Impact factor: 6.937

2.  Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation.

Authors:  B Frendéus; C Wachtler; M Hedlund; H Fischer; P Samuelsson; M Svensson; C Svanborg
Journal:  Mol Microbiol       Date:  2001-04       Impact factor: 3.501

3.  Interleukin-8 receptor deficiency confers susceptibility to acute pyelonephritis.

Authors:  B Frendéus; G Godaly; L Hang; D Karpman; C Svanborg
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

4.  Loss of regulatory protein RfaH attenuates virulence of uropathogenic Escherichia coli.

Authors:  Gábor Nagy; Ulrich Dobrindt; György Schneider; A Salam Khan; Jörg Hacker; Levente Emödy
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

5.  Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli.

Authors:  R A Welch; V Burland; G Plunkett; P Redford; P Roesch; D Rasko; E L Buckles; S-R Liou; A Boutin; J Hackett; D Stroud; G F Mayhew; D J Rose; S Zhou; D C Schwartz; N T Perna; H L T Mobley; M S Donnenberg; F R Blattner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-05       Impact factor: 11.205

6.  S-Fimbria-encoding determinant sfa(I) is located on pathogenicity island III(536) of uropathogenic Escherichia coli strain 536.

Authors:  U Dobrindt; G Blum-Oehler; T Hartsch; G Gottschalk; E Z Ron; R Fünfstück; J Hacker
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

7.  A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917.

Authors:  Lubomir Grozdanov; Ulrich Zähringer; Gabriele Blum-Oehler; Lore Brade; Anke Henne; Yuriy A Knirel; Ursula Schombel; Jürgen Schulze; Ulrich Sonnenborn; Gerhard Gottschalk; Jörg Hacker; Ernst T Rietschel; Ulrich Dobrindt
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

8.  Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise.

Authors:  J R Johnson; A L Stell
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

9.  Analysis of genome plasticity in pathogenic and commensal Escherichia coli isolates by use of DNA arrays.

Authors:  Ulrich Dobrindt; Franziska Agerer; Kai Michaelis; Andreas Janka; Carmen Buchrieser; Martin Samuelson; Catharina Svanborg; Gerhard Gottschalk; Helge Karch; Jörg Hacker
Journal:  J Bacteriol       Date:  2003-03       Impact factor: 3.490

10.  Sex and virulence in Escherichia coli: an evolutionary perspective.

Authors:  Thierry Wirth; Daniel Falush; Ruiting Lan; Frances Colles; Patience Mensa; Lothar H Wieler; Helge Karch; Peter R Reeves; Martin C J Maiden; Howard Ochman; Mark Achtman
Journal:  Mol Microbiol       Date:  2006-06       Impact factor: 3.501

View more
  46 in total

Review 1.  Asymptomatic bacteriuria: when the treatment is worse than the disease.

Authors:  Barbara W Trautner
Journal:  Nat Rev Urol       Date:  2011-12-06       Impact factor: 14.432

2.  Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli.

Authors:  Rebecca E Watts; Makrina Totsika; Victoria L Challinor; Amanda N Mabbett; Glen C Ulett; James J De Voss; Mark A Schembri
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

Review 3.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 4.  Genome dynamics and its impact on evolution of Escherichia coli.

Authors:  Ulrich Dobrindt; M Geddam Chowdary; G Krumbholz; J Hacker
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

5.  Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation.

Authors:  Viktoria Hancock; Rebecca Munk Vejborg; Per Klemm
Journal:  Mol Genet Genomics       Date:  2010-10-01       Impact factor: 3.291

6.  Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisition.

Authors:  Scott A Beatson; Nouri L Ben Zakour; Makrina Totsika; Brian M Forde; Rebecca E Watts; Amanda N Mabbett; Jan M Szubert; Sohinee Sarkar; Minh-Duy Phan; Kate M Peters; Nicola K Petty; Nabil-Fareed Alikhan; Mitchell J Sullivan; Jayde A Gawthorne; Mitchell Stanton-Cook; Nguyen Thi Khanh Nhu; Teik Min Chong; Wai-Fong Yin; Kok-Gan Chan; Viktoria Hancock; David W Ussery; Glen C Ulett; Mark A Schembri
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

Review 7.  Genetics of innate immunity and UTI susceptibility.

Authors:  Bryndís Ragnarsdóttir; Nataliya Lutay; Jenny Grönberg-Hernandez; Bela Köves; Catharina Svanborg
Journal:  Nat Rev Urol       Date:  2011-07-12       Impact factor: 14.432

8.  Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection.

Authors:  Swaine L Chen; Meng Wu; Jeffrey P Henderson; Thomas M Hooton; Michael E Hibbing; Scott J Hultgren; Jeffrey I Gordon
Journal:  Sci Transl Med       Date:  2013-05-08       Impact factor: 17.956

9.  Virulence potential of Escherichia coli strains causing asymptomatic bacteriuria during pregnancy.

Authors:  Jean-Philippe Lavigne; Adeline Boutet-Dubois; Dorsaf Laouini; Christophe Combescure; Nicole Bouziges; Pierre Marès; Albert Sotto
Journal:  J Clin Microbiol       Date:  2011-09-14       Impact factor: 5.948

10.  Epigenetic Mechanisms Regulate Innate Immunity against Uropathogenic and Commensal-Like Escherichia coli in the Surrogate Insect Model Galleria mellonella.

Authors:  Miriam Heitmueller; André Billion; Ulrich Dobrindt; Andreas Vilcinskas; Krishnendu Mukherjee
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.